Institutional investors purchased a net $3.1 million shares of CPHD during the quarter ended September 2014 and now own 108.62% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELLINGTON MANAGEMENT CO. LLP Bought 2.4 Million shares of Cepheid
GOLDMAN SACHS ASSET MANAGEMENT L... Bought 1.4 Million shares of Cepheid
CALAMOS ADVISORS LLC Bought 604.2 Thousand shares of Cepheid